{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:00:58Z","timestamp":1793815258605,"version":"4.6.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although well studied in families at high-risk, the roles of mutations in the BRCA1 and BRCA2 genes are poorly understood in breast cancers in the general population, particularly in Black women and in age groups outside of the very young. We examined the prevalence and predictors of BRCA1 and BRCA2 mutations in 1,628 women with breast cancer and 674 women without breast cancer who participated in a multicenter population-based case-control study of Black and White women, 35 to 64 years of age. Among cases, 2.4% and 2.3% carried deleterious mutations in BRCA1 and BRCA2, respectively. BRCA1 mutations were significantly more common in White (2.9%) versus Black (1.4%) cases and in Jewish (10.2%) versus non-Jewish (2.0%) cases; BRCA2 mutations were slightly more frequent in Black (2.6%) versus White (2.1%) cases. Numerous familial and demographic factors were significantly associated with BRCA1 and, to a lesser extent, BRCA2 carrier status, when examined individually. In models considering all predictors together, early onset ages in cases and in relatives, family history of ovarian cancer, and Jewish ancestry remained strongly and significantly predictive of BRCA1 carrier status, whereas BRCA2 predictors were fewer and more modest in magnitude. Both the combinations of predictors and effect sizes varied across racial\/ethnic and age groups. These results provide first-time prevalence estimates for BRCA1\/BRCA2 in breast cancer cases among understudied racial and age groups and show key predictors of mutation carrier status for both White and Black women and women of a wide age spectrum with breast cancer in the general population. (Cancer Res 2006; 66(16): 8297-308)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0503","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T17:20:57Z","timestamp":1155662457000},"page":"8297-8308","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":328,"title":["Prevalence and Predictors of <i>BRCA1<\/i> and <i>BRCA2<\/i> Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years"],"prefix":"10.1158","volume":"66","author":[{"given":"Kathleen E.","family":"Malone","sequence":"first","affiliation":[{"name":"1Public Health Sciences and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R.","family":"Daling","sequence":"additional","affiliation":[{"name":"1Public Health Sciences and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Doody","sequence":"additional","affiliation":[{"name":"1Public Health Sciences and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hsu","sequence":"additional","affiliation":[{"name":"1Public Health Sciences and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[{"name":"4Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Coates","sequence":"additional","affiliation":[{"name":"5National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Marchbanks","sequence":"additional","affiliation":[{"name":"5National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Simon","sequence":"additional","affiliation":[{"name":"6Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"McDonald","sequence":"additional","affiliation":[{"name":"5National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Norman","sequence":"additional","affiliation":[{"name":"7Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[{"name":"7Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald T.","family":"Burkman","sequence":"additional","affiliation":[{"name":"8Department of Obstetrics and Gynecology, Bay State Medical Center, Springfield, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[{"name":"4Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California;"},{"name":"9Department of Nutrition, University of Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Deapen","sequence":"additional","affiliation":[{"name":"4Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Weiss","sequence":"additional","affiliation":[{"name":"10Cancer Centers Branch, National Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Folger","sequence":"additional","affiliation":[{"name":"5National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Madeoy","sequence":"additional","affiliation":[{"name":"2Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center;"},{"name":"3Department of Genome Sciences, University of Washington, Seattle, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Friedrichsen","sequence":"additional","affiliation":[{"name":"2Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola M.","family":"Suter","sequence":"additional","affiliation":[{"name":"2Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela C.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"2Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spirtas","sequence":"additional","affiliation":[{"name":"11Contraception and Reproductive Branch, Center for Population Research, National Institute of Child Health and Human Development, NIH, DHHS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Ostrander","sequence":"additional","affiliation":[{"name":"2Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center;"},{"name":"12National Human Genome Research Institute\/NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"2022061622121404700_B1","doi-asserted-by":"crossref","unstructured":"Couch FJ, Deshano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med\u20081997; 336: 1409\u201315.","DOI":"10.1056\/NEJM199705153362002"},{"key":"2022061622121404700_B2","doi-asserted-by":"crossref","unstructured":"Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med\u20081997; 336: 1401\u20138.","DOI":"10.1056\/NEJM199705153362001"},{"key":"2022061622121404700_B3","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet\u20081998; 62: 676\u201389."},{"key":"2022061622121404700_B4","doi-asserted-by":"crossref","unstructured":"Warner E, Foulkes W, Goodwin P, et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst\u20081999; 91: 1241\u20137.","DOI":"10.1093\/jnci\/91.14.1241"},{"key":"2022061622121404700_B5","doi-asserted-by":"crossref","unstructured":"Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer\u20082000; 83: 1301\u20138.","DOI":"10.1054\/bjoc.2000.1407"},{"key":"2022061622121404700_B6","doi-asserted-by":"crossref","unstructured":"Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet\u20082001; 68: 700\u201310.","DOI":"10.1086\/318787"},{"key":"2022061622121404700_B7","doi-asserted-by":"crossref","unstructured":"Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet\u20082003; 72: 1117\u201330.","DOI":"10.1086\/375033"},{"key":"2022061622121404700_B8","doi-asserted-by":"crossref","unstructured":"Southey MC, Tesoriero AA, Andersen CR, et al. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer\u20081999; 79: 34\u20139.","DOI":"10.1038\/sj.bjc.6690008"},{"key":"2022061622121404700_B9","doi-asserted-by":"crossref","unstructured":"Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst\u20081999; 91: 943\u20139.","DOI":"10.1093\/jnci\/91.11.943"},{"key":"2022061622121404700_B10","doi-asserted-by":"crossref","unstructured":"Malone KE, Daling JR, Neal C, et al. Frequency of BRCA1\/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer\u20082000; 88: 1393\u2013402.","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P"},{"key":"2022061622121404700_B11","doi-asserted-by":"crossref","unstructured":"Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst\u20082001; 93: 1215\u201323.","DOI":"10.1093\/jnci\/93.16.1215"},{"key":"2022061622121404700_B12","doi-asserted-by":"crossref","unstructured":"de Sanjose S, Leone M, Berez V, et al. Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer\u20082003; 106: 588\u201393.","DOI":"10.1002\/ijc.11271"},{"key":"2022061622121404700_B13","unstructured":"Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet\u20081995; 57: 1457\u201362."},{"key":"2022061622121404700_B14","doi-asserted-by":"crossref","unstructured":"Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer\u20082003; 97: 236\u201345.","DOI":"10.1002\/cncr.11019"},{"key":"2022061622121404700_B15","doi-asserted-by":"crossref","unstructured":"Marchbanks PA, McDonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol\u20082002; 12: 213\u201321.","DOI":"10.1016\/S1047-2797(01)00274-5"},{"key":"2022061622121404700_B16","doi-asserted-by":"crossref","unstructured":"Eng C, Brody LC, Wagner TM, et al. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet\u20082001; 38: 824\u201333.","DOI":"10.1136\/jmg.38.12.824"},{"key":"2022061622121404700_B17","doi-asserted-by":"crossref","unstructured":"Wagner T, Stoppa-Lyonnet D, Fleischmann E, et al. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics\u20081999; 62: 369\u201376.","DOI":"10.1006\/geno.1999.6026"},{"key":"2022061622121404700_B18","doi-asserted-by":"crossref","unstructured":"Brzovic PS, Meza J, King MC, Klevit RE. The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain. J Biol Chem\u20081998; 273: 7795\u20139.","DOI":"10.1074\/jbc.273.14.7795"},{"key":"2022061622121404700_B19","doi-asserted-by":"crossref","unstructured":"Morris JR, Solomon E. BRCA1: BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum Mol Genet\u20082004; 13: 807\u201317.","DOI":"10.1093\/hmg\/ddh095"},{"key":"2022061622121404700_B20","doi-asserted-by":"crossref","unstructured":"Mazoyer S, Dunning AM, Serova O, et al. A polymorphic stop codon in BRCA2. Nat Genet\u20081996; 14: 253\u20134.","DOI":"10.1038\/ng1196-253"},{"key":"2022061622121404700_B21","doi-asserted-by":"crossref","unstructured":"McKnight B, Cook LS, Weiss NS. Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol\u20081999; 149: 984\u201392.","DOI":"10.1093\/oxfordjournals.aje.a009759"},{"key":"2022061622121404700_B22","doi-asserted-by":"crossref","unstructured":"Whittemore AS, Gong G, John EM, et al. Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 2078\u201383.","DOI":"10.1158\/1055-9965.2078.13.12"},{"key":"2022061622121404700_B23","doi-asserted-by":"crossref","unstructured":"Easton DF. Familial risks of breast cancer. Breast Cancer Res\u20082002; 4: 179\u201381.","DOI":"10.1186\/bcr448"},{"key":"2022061622121404700_B24","doi-asserted-by":"crossref","unstructured":"Anton-Culver H, Cohen PF, Gildea ME, Ziogas A. Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. Eur J Cancer\u20082000; 36: 1200\u20138.","DOI":"10.1016\/S0959-8049(00)00110-6"},{"key":"2022061622121404700_B25","doi-asserted-by":"crossref","unstructured":"Schubert EL, Mefford HC, Dann JL, Argonza RH, Hull J, King MC. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genet Test\u20081997; 1: 41\u20136.","DOI":"10.1089\/gte.1997.1.41"},{"key":"2022061622121404700_B26","doi-asserted-by":"crossref","unstructured":"Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet\u20081998; 352: 1337\u20139.","DOI":"10.1016\/S0140-6736(98)03300-5"},{"key":"2022061622121404700_B27","doi-asserted-by":"crossref","unstructured":"Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer\u20082002; 86: 76\u201383.","DOI":"10.1038\/sj.bjc.6600008"},{"key":"2022061622121404700_B28","doi-asserted-by":"crossref","unstructured":"Martin AM, Blackwood MA, Antin-Ozerkis D, et al. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol\u20082001; 19: 2247\u201353.","DOI":"10.1200\/JCO.2001.19.8.2247"},{"key":"2022061622121404700_B29","doi-asserted-by":"crossref","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol\u20082002; 20: 1480\u201390.","DOI":"10.1200\/JCO.2002.20.6.1480"},{"key":"2022061622121404700_B30","doi-asserted-by":"crossref","unstructured":"Shih HA, Couch FJ, Nathanson KL, et al. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol\u20082002; 20: 994\u20139.","DOI":"10.1200\/JCO.2002.20.4.994"},{"key":"2022061622121404700_B31","doi-asserted-by":"crossref","unstructured":"Nanda R, Schumm LP, Cummings S, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA\u20082005; 294: 1925\u201333.","DOI":"10.1001\/jama.294.15.1925"},{"key":"2022061622121404700_B32","doi-asserted-by":"crossref","unstructured":"Hodgson SV, Mohammed SN. Screening for breast cancer. Consider family history also. BMJ\u20081994; 309: 664.","DOI":"10.1136\/bmj.309.6955.664"},{"key":"2022061622121404700_B33","doi-asserted-by":"crossref","unstructured":"Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet\u20081999; 64: 963\u201370.","DOI":"10.1086\/302320"},{"key":"2022061622121404700_B34","doi-asserted-by":"crossref","unstructured":"Apicella C, Andrews L, Hodgson SV, et al. Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res\u20082003; 5: R206\u201316.","DOI":"10.1186\/bcr644"},{"key":"2022061622121404700_B35","doi-asserted-by":"crossref","unstructured":"King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science\u20082003; 302: 643\u20136.","DOI":"10.1126\/science.1088759"},{"key":"2022061622121404700_B36","doi-asserted-by":"crossref","unstructured":"Ozcelik H, Knight JA, Glendon G, et al. Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies. J Med Genet\u20082003; 40: e91.","DOI":"10.1136\/jmg.40.8.e91"},{"key":"2022061622121404700_B37","doi-asserted-by":"crossref","unstructured":"McKean-Cowdin R, Spencer FH, Xia LY, et al. BRCA1 variants in a family study of African-American and Latina women. Hum Genet\u20082005; 116: 497\u2013506.","DOI":"10.1007\/s00439-004-1240-5"},{"key":"2022061622121404700_B38","doi-asserted-by":"crossref","unstructured":"Kanaan Y, Kpenu E, Utley K, et al. Inherited BRCA2 mutations in African Americans with breast and\/or ovarian cancer: a study of familial and early onset cases. Hum Genet\u20082003; 113: 452\u201360.","DOI":"10.1007\/s00439-003-0999-0"},{"key":"2022061622121404700_B39","unstructured":"Gao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet\u20081997; 60: 1233\u20136."},{"key":"2022061622121404700_B40","doi-asserted-by":"crossref","unstructured":"Gao Q, Tomlinson G, Das S, et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet\u20082000; 107: 186\u201391.","DOI":"10.1007\/s004390000290"},{"key":"2022061622121404700_B41","unstructured":"Arena JF, Smith S, Plewinska M, et al. BRCA1 mutations in African American women [abstract 169]. The American Society of Human Genetics 46th Annual Meeting (San Francisco, CA). Am J Hum Genet Suppl;1996, A34."},{"key":"2022061622121404700_B42","doi-asserted-by":"crossref","unstructured":"Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 1794\u20139.","DOI":"10.1158\/1055-9965.1794.13.11"},{"key":"2022061622121404700_B43","doi-asserted-by":"crossref","unstructured":"Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA\u20081998; 279: 915\u201321.","DOI":"10.1001\/jama.279.12.915"},{"key":"2022061622121404700_B44","doi-asserted-by":"crossref","unstructured":"Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet\u20081999; 105: 72\u20138.","DOI":"10.1007\/s004399900092"},{"key":"2022061622121404700_B45","doi-asserted-by":"crossref","unstructured":"Wagner TM, Moslinger RA, Muhr D, et al. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer\u20081998; 77: 354\u201360.","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.0.CO;2-N"},{"key":"2022061622121404700_B46","unstructured":"Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet\u20081997; 60: 1013\u201320."},{"key":"2022061622121404700_B47","doi-asserted-by":"crossref","unstructured":"Lahti-Domenici J, Rapakko K, Paakkonen K, et al. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet\u20082001; 129: 120\u20133.","DOI":"10.1016\/S0165-4608(01)00437-X"},{"key":"2022061622121404700_B48","unstructured":"Hogervorst FBL, Nederlof PM, Gille JJP, et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res\u20082003; 63: 1449\u201353."},{"key":"2022061622121404700_B49","doi-asserted-by":"crossref","unstructured":"Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet\u20081998; 62: 145\u201358.","DOI":"10.1086\/301670"},{"key":"2022061622121404700_B50","doi-asserted-by":"crossref","unstructured":"Chatterjee N, Kalaylioglu Z, Shih JH, Gail H. Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics\u20082006; 62: 36\u201348.","DOI":"10.1111\/j.1541-0420.2005.00442.x"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/16\/8297\/2551474\/8297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/16\/8297\/2551474\/8297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:10:58Z","timestamp":1655424658000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/16\/8297\/525926\/Prevalence-and-Predictors-of-BRCA1-and-BRCA2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":50,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2006,8,15]]},"published-print":{"date-parts":[[2006,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0503","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]}}}